YMAB icon

Y-mAbs Therapeutics
YMAB

Overview Fund Activity

95 hedge funds and large institutions have $132M invested in Y-mAbs Therapeutics in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
+10
Holders Change %
+11.76%
% of All Funds
1.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
32
Reduced
30
Closed
10
Calls
$36K
Puts
$11K
Net Calls
+$25K
Net Calls Change
-$23K

Top Buyers

1
D.E. Shaw & Co
1
D.E. Shaw & Co
New York
$8.66M
2
Los Angeles Capital Management
2
Los Angeles Capital Management
California
$1.84M
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$4.44M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$3.83M
5
Goldman Sachs
5
Goldman Sachs
New York
$2.73M

Top Sellers

1
ACM
1
AIGH Capital Management
Maryland
$0
2
Millennium Management
2
Millennium Management
New York
$2.24M
3
AQR Capital Management
3
AQR Capital Management
Connecticut
$1.35M
4
Citadel Advisors
4
Citadel Advisors
Florida
$214K
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$262K
Name Holding Trade Value Shares
Change 		Shares
Change %
DTL
101
Dynamic Technology Lab
Singapore
– -$128K -25,478 Closed
VF
102
Virtu Financial
New York
– -$126K -25,147 Closed
SG Americas Securities
103
SG Americas Securities
New York
– -$109K -21,735 Closed
PVH
104
Psagot Value Holdings
Israel
– -$3K -800 Closed
1 2 3 4
5